CTOs on the Move

Boston MicroFluidics

www.bostonmicrofluidics.com

 
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Boston MicroFluidics raised $17.5M on 08/27/2019

Similar Companies

Wellness Springs

Wellness Springs is a Highland Mills, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INVIVO

Locally-owned, INVIVO Wellness specializes in an integrated and whole-person approach to wellness and self-care healing. We are experts in the fields of physical therapy, massage therapy, chiropractic, yoga therapy, mental wellness, personal training a...

St. Joseph of the Pines Health System

St. Joseph of the Pines Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. St. Joseph of the Pines Health System is based in Newark, NJ. You can find more information on St. Joseph of the Pines Health System at www.sjp.org

American Transplant Foundation

American Transplant Foundation is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Design

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches designed to enable the body`s immune system to fight disease. The company`s technologies are engineered to activate the immune system`s natural ability to create tumor-specific cytotoxic T cells to fight cancer and other chronic disease. Immune Design`s clinical programs are the product of its two synergistic platforms: DCVexTM and GLAASTM.